NCT07648238

Brief Summary

The purpose of this study is to establish the clinical efficacy of Mentalizing Imagery Therapy (MIT) for Alzheimer's Disease and Related Disorders (ADRD) family caregivers in terms of mentalizing and elder mistreatment (EM) risk factors of stress, depression, and suicidality and to identify the mechanistic impacts of MIT on ADRD family caregivers' mental health,including stress, depression, and suicidality.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
23mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 15, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

June 15, 2026

Status Verified

June 1, 2026

Enrollment Period

1.1 years

First QC Date

June 9, 2026

Last Update Submit

June 9, 2026

Conditions

Keywords

Mentalizing Imagery TherapyMindfulness Exercisesdementia family caregiver

Outcome Measures

Primary Outcomes (1)

  • Change in perceived stress as measured by self-reported daily stress

    This is scored on a scale from 0-10, with 0 indicating no stress, and 10 indicating the day was extremely stressful

    From Baseline through Week 10

Secondary Outcomes (8)

  • Change in perceived stress as measured by Perceived Stress Scale (PSS)

    Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10

  • Change in depression as measured by Patient Health Questionnaire-9 (PHQ-9)

    Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10

  • Depression as measured by self-rated daily depression severity

    From baseline through Week 10

  • Suicidality as measured by self-reported daily suicidality

    From baseline through Week 10

  • Change in Mentalization as Measured by the Mentalization Questionnaire (MZQ)

    Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10

  • +3 more secondary outcomes

Study Arms (2)

4 weeks of MIT followed by 4 weeks of ME with 2 weeks of washout period in between

EXPERIMENTAL
Behavioral: Mentalizing Imagery TherapyBehavioral: Mindfulness Exercises.

4 weeks of ME, followed by 4 weeks of MIT with 2 weeks of washout period in between

EXPERIMENTAL

Interventions

MIT is a 4-week, app-delivered behavioral program integrating guided imagery, mindfulness, and perspective-taking practices designed to enhance mentalizing, emotion regulation, and self compassion. MIT is reinforced by weekly 90-minute virtual group sessions

4 weeks of MIT followed by 4 weeks of ME with 2 weeks of washout period in between

Mindfulness exercises (ME) is a 4-week, app-delivered program featuring daily self-guided mindfulness practices and reflective exercises aimed at reducing depression and stress.ME is self-guided and does not include group sessions.

4 weeks of MIT followed by 4 weeks of ME with 2 weeks of washout period in between

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Primary family ADRD caregivers
  • Recruited nationally.
  • Caring for someone aged 60 or older
  • Provide at least 8 hours of care weekly
  • Report at least mild depressive symptoms (PHQ-9 ≥5)
  • Use a smartphone at least five days per week.

You may not qualify if:

  • Active psychosis or mania
  • A suicide attempt in the last 6 months or current suicidal intent
  • Self-reported memory or cognitive complaints
  • Unstable medical conditions or planned major surgery
  • Moderate to severe substance use disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Psychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Study Officials

  • Wesley Browning, PhD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 9, 2026

First Posted

June 15, 2026

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

June 30, 2028

Last Updated

June 15, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations